MALVERN, Pa., July 29, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on the discovery, development and commercialization of novel gene and cell therapies and vaccines, today announced that it will host a conference call and live webcast on Thursday, August 8, 2024 at 8:30 a.m. ET to discuss the Company’s second quarter 2024 financial results and provide an update on its business.
Ocugen will make a pre-market earnings release on the same day. Participants can join the conference call using the details below.
Dial-in number: (800) 715-9871 within the U.S.; (646) 307-1963 internationally
Conference ID: 7453742
Webcast: Available on the Ocugen investor site in the Events section
A recording of the conference call and an archived webcast will be available on Ocugen’s investor relations site for approximately 45 days following the event.
About Ocugen, Inc.
Ocugen, Inc. is a biotechnology company focused on discovering, developing and commercializing novel gene and cell therapies and vaccines that improve the health and give hope to patients around the world. We are blazing new scientific trails leveraging our unique intellectual and human capital to impact patients’ lives through courageous innovation. Our breakthrough modified gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing infectious disease research to support public health and orthopedic disease research to address unmet medical needs. For more information, please visit www.ocugen.com and follow us on X and LinkedIn.
Caution Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the qualitative assessment of available data, potential benefits, expectations of ongoing clinical trials, anticipated regulatory filings and expected development timelines, which are subject to risks and uncertainties. In some cases, we may identify these forward-looking statements by using terms such as “anticipate,” “believe,” “potential,” “propose,” “continue,” “estimate,” “project,” “expect,” “plan,” “intend,” “may,” “could,” “might,” “will,” “should,” or other words that convey uncertainty of future events or outcomes. These statements are subject to a number of important factors, risks and uncertainties that could cause actual events or results to differ materially from our current expectations. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (SEC), including the risk factors described in the “Risk Factors” section of our quarterly and annual reports filed with the SEC. The forward-looking statements contained in this press release speak only as of the date of this press release. Except as required by law, the Company undertakes no obligation to update any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, after the date of this press release.
contact:
Tiffany Hamilton
Communications Director
TiffanyHamilton@ocugen.com
